BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 26081538)

  • 1. [The disease burden of malignant tumor in China, 1990 and 2010].
    Liu Y; Liu J; Yin P; Liu S; Cai Y; You J; Zeng X; Wang L; Zhou M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Apr; 49(4):309-14. PubMed ID: 26081538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of Disease Burden Factors of Thyroid Cancer Between China and the World From 1990 to 2019].
    Su W; Xu YT; Wang YN; Wu YY; Wan W; Gao WQ; Gao Y; Shi YY; Ma S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):940-948. PubMed ID: 38173105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of disease burden of lung cancer attributable to chromium in Chinese population from 1990 to 2019].
    Xiao SH; Wu PH; Han L; Liu X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Nov; 41(11):825-831. PubMed ID: 38073209
    [No Abstract]   [Full Text] [Related]  

  • 4. [Burden of pediatric cancer in Jiangxi, China, in 2010 and 2015].
    Xu G; Chen Y; Liu J; Liu SW; Wang P; Yang J; Huang JL
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jan; 20(1):21-27. PubMed ID: 29335077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular diseases burden attributed to low physical activity in China, 1990-2019].
    Liu YR; Chen QM; Liu M; Yin P; Zhou MG; Jia AN; Bai YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Jan; 45(1):105-111. PubMed ID: 38228531
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis and prediction of burden of viral hepatitis C-associated diseases in China from 1990 to 2044].
    Zhou M; Yao L; Wu Y; Lin S; Huang J
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Dec; 35(5):476-485. PubMed ID: 38148536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The non-fatal burden of cancer in Belgium, 2004-2019: a nationwide registry-based study.
    Gorasso V; Silversmit G; Arbyn M; Cornez A; De Pauw R; De Smedt D; Grant I; Wyper GMA; Devleesschauwer B; Speybroeck N
    BMC Cancer; 2022 Jan; 22(1):58. PubMed ID: 35026995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Burden of hepatitis B-associated diseases in China from 1990 to 2030].
    Yao L; Lin S; Huang J; Wu Y
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Nov; 35(5):464-475. PubMed ID: 38148535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the latest cancer statistics, cancer epidemic trends and determinants between China and the United States].
    Ji YT; Liu SW; Zhang YM; Duan HY; Liu XM; Feng ZW; Li JJ; Lyu ZY; Huang YB
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46():1-11. PubMed ID: 38764329
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020.
    Qiu H; Cao S; Xu R
    Cancer Commun (Lond); 2021 Oct; 41(10):1037-1048. PubMed ID: 34288593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of malaria in Ethiopia, 2000-2016: findings from the Global Health Estimates 2016.
    Girum T; Shumbej T; Shewangizaw M
    Trop Dis Travel Med Vaccines; 2019; 5():11. PubMed ID: 31338202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden and trend of liver metastases in Shanghai, China: a population-based study.
    Zheng HC; Zhou J; Chen YC; Yu Y; Dai W; Han Y; Li XP; Jiang SF
    Eur J Cancer Prev; 2023 Nov; 32(6):517-524. PubMed ID: 37401477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and trends of mortality from metastatic colorectal cancer in Shanghai, China from 2005 to 2021: a population-based retrospective analysis.
    Cheng X; Zhou J; Chen Y; Zhao Y; Zheng H; Wang Q; Li X; Jiang S
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):68. PubMed ID: 38305905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Trend and Cause of Mortality Burden in Infancy - China, 1990-2019.
    Wang C; Xu T
    China CDC Wkly; 2021 Apr; 3(16):340-345. PubMed ID: 34594880
    [No Abstract]   [Full Text] [Related]  

  • 15. High prevalence and burden of osteoarthritis in China.
    Wei J
    Lancet Rheumatol; 2020 Mar; 2(3):e127-e128. PubMed ID: 38263647
    [No Abstract]   [Full Text] [Related]  

  • 16. Growing Burden of Hypertension in China: Causes, Challenges, and Opportunities.
    Shi Z; Sun X; Yan AF; Wang Y
    China CDC Wkly; 2020 Oct; 2(40):776-779. PubMed ID: 34594765
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer statistics in China, 2015.
    Chen W; Zheng R; Baade PD; Zhang S; Zeng H; Bray F; Jemal A; Yu XQ; He J
    CA Cancer J Clin; 2016; 66(2):115-32. PubMed ID: 26808342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and Regional Distribution Pattern of Female Lung Cancer - China, 1992-2016.
    Ni X; Zhang B; Xu N; Zeng X; Wang Q
    China CDC Wkly; 2020 Aug; 2(32):614-618. PubMed ID: 34594721
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations of Oral Microbiota in Chinese Patients With Esophageal Cancer.
    Zhao Q; Yang T; Yan Y; Zhang Y; Li Z; Wang Y; Yang J; Xia Y; Xiao H; Han H; Zhang C; Xue W; Zhao H; Chen H; Wang B
    Front Cell Infect Microbiol; 2020; 10():541144. PubMed ID: 33194789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
    Zhang X; Liu T; Zheng S; Liu Q; Shen T; Han X; Zhang Q; Yang L; Lu X
    Oncol Rep; 2020 Oct; 44(4):1355-1364. PubMed ID: 32945483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.